在免疫检查点抑制剂治疗期间住院病人的表征:来自ICOG研究的见解
Jonas Paul Wiegmann1,2, Tabea Fröhlich1,2, Nora Möhn2,3
1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Cancer medicine
|January 26, 2025
概括
由于免疫检查点抑制剂 (ICI) 的免疫相关不良事件 (irAEs) 导致的住院病例发生在12.6%的患者中,主要是大肠炎和脑膜炎. 这些住院没有对整体存活率产生负面影响,支持门诊ICI治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要,但因免疫相关不良事件 (irAEs) 住院的数据有限.
- 这项研究描述了接受ICI治疗的患者住院的情况.
研究的目的:
- 在接受ICI治疗的患者中分析与irAEs相关的住院住院的特征和结果.
- 评估这些住院治疗对整体存活率的影响.
主要方法:
- 一项前性队列研究包括237名在2019年12月至2022年6月期间接受ICI治疗的患者.
- 在6个月内收集了临床特征,ICI类型和住院病例的数据.
- 用描述性和卡普兰-梅尔统计数据进行分析.
主要成果:
- 在观察期内,12.6%的患者 (30/237) 住院 (HA(+)) 在医院.
- 恶性黑色素瘤,细胞癌和非小细胞肺癌是最常见的癌症.
- 双重ICI (Nivolumab/Ipilimumab) 的住院病例显著增加,主要是因为结肠炎 (26.7%) 和下炎 (13.3%).
- 住院时间中位数为7天,经常进行跨学科咨询 (胃肠病学,神经病学).
结论:
- 住院率为12.6%,与先前的研究相比,结肠炎和肝炎是不成比例地代表导致入院的irAEs.
- 尽管住院患者的生存时间趋长,但与非住院患者相比,没有发现统计学上显著的差异.
- 这些发现支持ICI治疗的门诊管理,强调跨学科的合作和对irAEs的警监测.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Drug Administration and Therapy Phases: Overview
406
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
406


